These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 10678282)

  • 1. Risk stratification in hypertension: new insights from the Framingham Study.
    Kannel WB
    Am J Hypertens; 2000 Jan; 13(1 Pt 2):3S-10S. PubMed ID: 10678282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic appraisal of hypertension as a coronary risk factor in the elderly.
    O'Donnell CJ; Kannel WB
    Am J Geriatr Cardiol; 2002; 11(2):86-92. PubMed ID: 11872966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Framingham Study: ITS 50-year legacy and future promise.
    Kannel WB
    J Atheroscler Thromb; 2000; 6(2):60-6. PubMed ID: 10872616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fifty years of Framingham Study contributions to understanding hypertension.
    Kannel WB
    J Hum Hypertens; 2000 Feb; 14(2):83-90. PubMed ID: 10723112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and epidemiology of heart failure.
    Kannel WB
    Heart Fail Rev; 2000 Jun; 5(2):167-73. PubMed ID: 16228142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience).
    Kannel WB
    Am J Cardiol; 1996 Feb; 77(6):6B-11B. PubMed ID: 8848993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.
    Meigs JB; D'Agostino RB; Wilson PW; Cupples LA; Nathan DM; Singer DE
    Diabetes; 1997 Oct; 46(10):1594-600. PubMed ID: 9313755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension as a risk factor for cardiac events--epidemiologic results of long-term studies.
    Kannel WB
    J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S27-37. PubMed ID: 7692148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factor clustering in hypertensive patients: impact of the reports of NCEP-II and second joint task force on coronary prevention on JNC-VI guidelines.
    Stern N; Grosskopf I; Shapira I; Kisch E; Isaacov A; Limor R; Baz M; Leshem Y; Flatau E; Miller A; Greenman Y
    J Intern Med; 2000 Sep; 248(3):203-10. PubMed ID: 10971786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative importance of borderline and elevated levels of coronary heart disease risk factors.
    Vasan RS; Sullivan LM; Wilson PW; Sempos CT; Sundström J; Kannel WB; Levy D; D'Agostino RB
    Ann Intern Med; 2005 Mar; 142(6):393-402. PubMed ID: 15767617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure.
    Kannel WB
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():199-212. PubMed ID: 9211012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure as a cardiovascular risk factor: prevention and treatment.
    Kannel WB
    JAMA; 1996 May 22-29; 275(20):1571-6. PubMed ID: 8622248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Office assessment of coronary candidates and risk factor insights from the Framingham study.
    Kannel WB
    J Hypertens Suppl; 1991 Dec; 9(7):S13-9. PubMed ID: 1838769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
    Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA
    CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of multiple risk factors on the hazard of hypertension.
    Kannel WB
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S53-7. PubMed ID: 11527137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and acute coronary syndrome.
    Caccamo G; Bonura F; Bonura F; Vitale G; Novo G; Evola S; Evola G; Grisanti MR; Novo S
    Atherosclerosis; 2010 Aug; 211(2):672-5. PubMed ID: 20466373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia.
    Flack JM; Sowers JR
    Am J Med; 1991 Jul; 91(1A):11S-21S. PubMed ID: 1867224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of subjects at high risk of coronary disease in a working population using a prediction model].
    Laurier D; Chau NP
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1569-75. PubMed ID: 8745990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.